Interleukin-1 inhibitors in the treatment of diseases
OwnerJohn E. Sims, Larry F. O'Nealinventors
Life of this patent
Estimating the term…
Abstract
The invention pertains to methods for treating medical disorders characterized by elevated levels or abnormal expression of IL-1 by administering an IL-1 antagonist, such as soluble type II IL-receptor.
Claims12
A method of treating a patient afflicted with a medical disorder selected from the group consisting of Alzheimer's, stroke, head trauma, myocardial infarction, heart failure, acute coronary syndrome, periodontal disease, inflammatory bowel disease, asthma and pancreatitis, the method comprising administering to said patient a therapeutically effective amount of an IL-1 receptor.
A method of treating a patient afflicted with stroke, the method comprising administering to the patient a therapeutically effective amount of type II IL-1 receptor.
A method of treating a patient afflicted with heart failure, the method comprising administering to the patient a therapeutically effective amount of type II IL-1 receptor.
Dependencies are inferred from the claim text.